Private Equity Profile
In the last 3 years, Ascendent Capital Partners has acquired 1 company.
Ascendent Capital Partners’ most common sector for investment is life science (100%). The Firm’s most common investment types include going private (100%). In total, Ascendent Capital Partners has invested in 1 US state. Its largest (disclosed) acquisition occurred in 2017 when it acquired SciClone Pharmaceuticals for $605M.
Join Mergr to view Ascendent Capital Partners’ full profile and discover more middle-market private equity firms just like it.
M&A Total Activity1
- M&A Buy Activity1
- Total Sectors Invested 1
- Total Countries Invested 1
- M&A Advisors 2